Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02769026 · ClinicalTrials.gov registry record

Prognostication Biomarkers in Pediatric Cardiac Arrest

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
164
Enrollment target

NCT02769026 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 164 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02769026 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
164 participants
Enrollment target

Study Summary

This multicenter study will validate a panel of serum, imaging, and clinical biomarkers to classify patient outcome early after out-of-hospital pediatric cardiac arrest. Results are expected to have a positive and immediate impact in advancing clinical care and outcomes for these children. This work will provide clinicians, families, and researchers with superior tools to assess the severity of brain injury early after resuscitation in order to know who is at risk of brain injury and may benefit from neuroprotective interventions, to monitor response to these interventions, to plan rehabilitation strategy, and to optimize the design of research studies that test novel interventions to improve neurological outcome after cardiac arrest.

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2017-06-01
Est. Completion 2021-03-01

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02769026

The ClinicalTrials.gov registry entry for NCT02769026 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02769026 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02769026 about?

NCT02769026 is a clinical study titled "Prognostication Biomarkers in Pediatric Cardiac Arrest". This multicenter study will validate a panel of serum, imaging, and clinical biomarkers to classify patient outcome early after out-of-hospital pediatric cardiac arrest. Results are expected to have a positive and immediate impact in advancing clinical care and outcomes for these children. This work...

What is the current status of trial NCT02769026?

This trial is currently completed. The enrollment target is 164 participants. The study started on 2017-06-01. Estimated completion is 2021-03-01.

Who is sponsoring clinical trial NCT02769026?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.